Non-Selective Beta-Blockers in Patients with Cirrhosis: Current Evidence and Controversy
<p id="p2">Non-selective beta-blockers (NSBBs) are the cornerstone of management of liver cirrhosis and its complications. They decrease portal vein blood flow and portal vein pressure via antagonism of β<sub>1</sub> and β<sub>2</sub> receptors, thereby improving the hyperdynamic circulato...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2024
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/1190794 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|